← Open Payments lookup

JAMES LUKAS: Open Payments

NPI 1083120687 · CUMBERLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,501 in 67 payments from 11 companies in 2025. Trend: 2023 $1,295 · 2024 $1,721 · 2025 $1,501

Food & beverage: $1,392Education: $109
CompanyPaymentsAmount
ABBVIE INC.27$477
Teva Pharmaceuticals USA, Inc.13$420
Axsome Therapeutics, Inc.7$161
Neurocrine BioSciences, Inc.7$155
E.R. Squibb & Sons, L.L.C.5$101
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$52
Janssen Pharmaceuticals, Inc2$45
Lundbeck LLC1$28
Alkermes, Inc.1$24
Otsuka America Pharmaceutical, Inc.1$20

Products named: VRAYLAR, AUSTEDO XR, Auvelity, INGREZZA, COBENFY, UZEDY, CAPLYTA, REXULTI.

Industry payments across MD — which companies pay providers there.